Cannabis Science Inc (fka CBIS)

[sicofbs]

See...he releases products and pockets the cash I guess....so Dabney, we pay for everything and you keep the money??? Love this old press release.....dabney you already did this...lmao... the same press releases over and over !!!! I love how he throws out the packaging issue like its a whole new world....lmao..Dabney your not even a good liar....

CANNABIS SCIENCE, INC. (CBIS) GETS SET TO RELEASE ITS 8 INITIAL CANNABIS-BASED PRODUCTS PRODUCED AND DISTRIBUTED IN CALIFORNIA, SPAIN, AND THE NETHERLANDS FOR SELF-MEDICATING PATIENT USAGE FOR CRITICAL AILMENTS AND PRE-CLINICAL STUDIES

COLORADO SPRINGS, Colo., Jan. 16, 2015 /PRNewswire/ -- Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced on January 5th the International release of eight initial products to be produced, distributed and marketed across the Netherlands, Spain and California, where Cannabis Science is active and has cannabis production facilities through ownership and usage agreements.

The products are currently ready for pre-clinical studies, self-medicating patient ailment usage, marketing release, sales and distribution. The roll-out will involve Cannabis Science teams in both Europe and California to work in tandem to share information, send formulations to be produced in each respective production facility and share opt-in patient data based on usage metrics to scale demand, while collecting insightful information in each geographical market appropriately.

Preliminary packaging is now being secured and designs are completed for each jurisdiction. Please visit the beta version of the Cannabis Science Patient Access Center (PAC) http://pac.cannabisscience.com for product release information, patient usage tracking, share your usage and support stories with others worldwide, and valuable industry updates.
Cannabis Science will be announcing shortly where products are available for purchase in each jurisdiction; initial cannabis formulations will be focused on:

Topical formulations for cancers
Ingestible formulations for cancers, HIV/AIDS and other indications
Varied formulations for neurological disorders and other indications depending on delivery methodology required
Ingestible and topical formulations for chemotherapy side effects, chronic pain, muscle problems, sleeping disorders, nausea, ADHD, rheumatism, arthritis, infections, diabetes, manic depression, fibromyalgia and other issues
Topical formulations for rheumatism, fibromyalgia, arthritis, eczema, sporting injuries, radiotherapy wounds, muscle and neck pain, radiotherapy wounds, rheumatism, open